FDA Clearance Tracker · P210037-S011
Prospera Spinal Cord Stimulation (SCS) System, Resilience Percutaneous Lead, HomeStream Remote Management
Last checked: Nov 20, 2026Latest source record: Jun 25, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jun 25, 2025
Approved
Time to decision
82 days
Received Apr 4, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P210037-S011
- Device name
- Prospera Spinal Cord Stimulation (SCS) System, Resilience Percutaneous Lead, HomeStream Remote Management
- Applicant
- Biotronik Nro, Inc.
- Applicant location
- Lake Oswego, OR
- Received
- Apr 4, 2025
- Decided
- Jun 25, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P210037
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for changes made to the Prospera SCS System embedded software (implant software [ISW]) and Neuro Service Center (NSC). Specifically, the Prospera SCS System embedded software (ISW) was updated to version 1.0.3, which included changes to the lead impedance measurements algorithm to provide more information during intraoperative testing and improve the accuracy of calculation of resistive measurements. The NSC was updated to version 1.6.3, which included changes to allow magnetic resonance imaging (MRI) mode entry if the automated lead impedance measurements are within range for the three most recent days and the consideration of touching leads condition as safe for MRI.
Source documents
Other decisions for Biotronik Nro, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P210037 · Decided Mar 31, 2023 · 484 days after receipt
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.